TDC
CME icon

Thompson Davis & Co’s CME Group CME Stock Holding History

Thompson Davis & Co’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-23
Closed -$3K – 1090
2017
Q1 		$3K Sell
23
-17
-43% -$2.04K ﹤0.01% 982
2016
Q4 		$5K Hold
40
– – 0.01% 848
2016
Q3 		$4K Hold
40
– – 0.01% 864
2016
Q2 		$4K Buy
40
+30
+300% +$2.83K 0.01% 821
2016
Q1 		$1K Sell
10
-79
-89% -$7.19K ﹤0.01% 1002
2015
Q4 		$8K Buy
89
+10
+13% +$941 0.01% 707
2015
Q3 		$7K Buy
+79
New +$7.51K 0.01% 760
2015
Q1 		– Sell
-47
Closed -$4K – 1185
2014
Q4 		$4K Sell
47
-9
-16% -$763 ﹤0.01% 976
2014
Q3 		$4K Buy
+56
New +$4.22K 0.01% 931

Other funds holding CME

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Thompson Davis & Co's CME Position: Q2 2017 in Review

Thompson Davis & Co sold out of CME Group (CME) in Q2 2017, closing a stake of 23 shares — an estimated $3K sold.

Thompson Davis & Co first reported a position in CME in Q3 2014 and held it in 9 quarters. The position peaked at $8K in Q4 2015. 772 funds tracked by Wall St. Rank hold CME as of Q2 2017.

  • Thompson Davis & Co reported no remaining CME Group position as of Q2 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 23 CME Group shares in Q2 2017, an estimated $3K.
  • Thompson Davis & Co first reported a position in CME Group in Q3 2014 and held it in 9 quarters.
  • Thompson Davis & Co's CME Group position peaked at $8K in Q4 2015.
  • 772 funds tracked by Wall St. Rank held CME Group as of Q2 2017.

Based on Thompson Davis & Co's 13F filing for Q2 2017, filed 10 Aug 2017.